company background image
4160 logo

Genetics Generation Advancement TPEX:4160 Stock Report

Last Price

NT$69.30

Market Cap

NT$1.8b

7D

-10.0%

1Y

83.9%

Updated

21 Dec, 2024

Data

Company Financials

Genetics Generation Advancement Corp.

TPEX:4160 Stock Report

Market Cap: NT$1.8b

4160 Stock Overview

Provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. More details

4160 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Genetics Generation Advancement Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genetics Generation Advancement
Historical stock prices
Current Share PriceNT$69.30
52 Week HighNT$150.87
52 Week LowNT$36.17
Beta0.54
1 Month Change-19.14%
3 Month Change-24.76%
1 Year Change83.85%
3 Year Change208.84%
5 Year Change176.89%
Change since IPO64.86%

Recent News & Updates

Recent updates

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Feb 25
Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Shareholder Returns

4160TW BiotechsTW Market
7D-10.0%-2.6%-2.1%
1Y83.9%-0.8%25.6%

Return vs Industry: 4160 exceeded the TW Biotechs industry which returned -0.8% over the past year.

Return vs Market: 4160 exceeded the TW Market which returned 25.6% over the past year.

Price Volatility

Is 4160's price volatile compared to industry and market?
4160 volatility
4160 Average Weekly Movement5.6%
Biotechs Industry Average Movement4.5%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4160 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4160's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/an/awww.gga.asia

Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-pregnancy test, pregnancy test, newborn testing, adult health management genetic testing, adult cancer and pharmacogenetic testing, and cooperative institutes. It also provides life sciences, materials sciences, laboratory informatics, enterprise quality management system, MES, electronic delivery services.

Genetics Generation Advancement Corp. Fundamentals Summary

How do Genetics Generation Advancement's earnings and revenue compare to its market cap?
4160 fundamental statistics
Market capNT$1.85b
Earnings (TTM)NT$58.49m
Revenue (TTM)NT$664.37m

31.6x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4160 income statement (TTM)
RevenueNT$664.37m
Cost of RevenueNT$381.42m
Gross ProfitNT$282.95m
Other ExpensesNT$224.46m
EarningsNT$58.49m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.19
Gross Margin42.59%
Net Profit Margin8.80%
Debt/Equity Ratio5.2%

How did 4160 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

22%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genetics Generation Advancement Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.